Animals

PS Prasad Srikakulapu
AU Aditi Upadhye
SR Sam M. Rosenfeld
MM Melissa A. Marshall
CM Chantel McSkimming
AH Alexandra W. Hickman
IM Ileana S. Mauldin
GA Gorav Ailawadi
ML M. Beatriz S. Lopes
AT Angela M. Taylor
CM Coleen A. McNamara
ask Ask a question
Favorite

All animal protocols were approved by the Animal Care and Use Committee at the University of Virginia. Apolipoprotein E deficient (ApoE−/−) mice were purchased from Jackson Laboratory and maintained in our animal facility (University of Virginia). Id3fl/fl mice were a generous gift from Dr. Yuan Zhang (Duke University). CD19Cre/+ mice were provided by Timothy Bender (University of Virginia). Id3fl/fl mice were bred to the ApoE−/− line and then with CD19Cre/+ mice to develop B cell specific Id3 knockouts and littermate controls (ApoE−/−Id3WT: ApoE−/−.CD19+/+.Id3fl/fl and ApoE−/−Id3BKO: ApoE−/−.CD19Cre/+.Id3fl/fl) as previously described (Perry et al., 2013). All purchased mice were on C57BL/6J background and those bred were backcrossed to C57BL/6J mice for 10 generations. All mice were given water ad libitum and standard chow diet (Tekland, 7012). Mice were euthanized with CO2 inhalation. Young (8–10 weeks) male mice were used for all experiments except for atherosclerosis studies. For atherosclerosis studies, ApoE−/− mice were maintained on WD (42% fat, Tekland, 88137) for 12 weeks.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A